Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | KIF11 | P52732 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 3/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | ALPL | P05186 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | GAK | O14976 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8135398 | 0.84 | CYP11B1 (0.31) | CA1CA2 | |
| SCHEMBL5054248 | 0.82 | TSHR (0.34) | TSHR | |
| SCHEMBL160761 | 0.82 | L3MBTL1 (0.37) | ALDH1A1HPGDHSD17B10KIF11MAPT | |
| SCHEMBL28826291 | 0.80 | CYP19A1 (0.34) | — | |
| SCHEMBL2767797 | 0.79 | ALDH1A1 (0.31) | ALDH1A1HPGDALOX15HSD17B10TDP1 | |
| SCHEMBL5477987 | 0.79 | ALDH1A1 (0.34) | ALDH1A1HPGDALOX15HSD17B10TDP1 | |
| SCHEMBL28088212 | 0.77 | ACHE (0.40) | ALDH1A1HPGDHSD17B10TDP1KIF11 | |
| SCHEMBL27660860 | 0.74 | KDM4E (0.33) | HSD17B10MAPTRECQL | |
| SCHEMBL14054015 | 0.74 | ATM (0.30) | — | |
| SCHEMBL4858324 | 0.73 | CYP3A4 (0.33) | ALDH1A1HSD17B10TDP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115297861-B | Compounds and uses thereof | 福宏治疗公司 | 2024-07-12 | — | — | CN | claimed |
| US-20230145003-A1 | COMPOUNDS AND USES THEREOF | FOGHORN THERAPEUTICS INC. | 2023-05-11 | — | — | US | claimed |
| US-20220000877-A1 | AQUEOUS COMPOSITION, IN PARTICULAR FOR TREATING MUCOSA AND/OR WOUNDS | B. BRAUN MELSUNGEN AG (DE) | 2022-01-06 | — | — | US | claimed |
| US-20210401848-A1 | AQUEOUS COMPOSITION, IN PARTICULAR FOR TREATING MUCOSA AND/OR WOUNDS | B. BRAUN MELSUNGEN AG (DE) | 2021-12-30 | — | — | US | claimed |
| EP-3886804-A1 | AQUEOUS COMPOSITION, IN PARTICULAR FOR TREATING MUCOSA AND/OR WOUNDS | B. Braun Melsungen AG (DE) | 2021-10-06 | — | — | EP | claimed |
| EP-3886805-A1 | AQUEOUS COMPOSITION, IN PARTICULAR FOR TREATING MUCOSA AND/OR WOUNDS | B. Braun Melsungen AG (DE) | 2021-10-06 | — | — | EP | claimed |
| CN-113347960-A | Aqueous composition, in particular for the treatment of mucous membranes and/or wounds | B.布劳恩梅尔松根股份公司 | 2021-09-03 | — | — | CN | claimed |
| CN-113271924-A | Aqueous composition, in particular for the treatment of mucous membranes and/or wounds | B.布劳恩梅尔松根股份公司 | 2021-08-17 | — | — | CN | claimed |
| CN-115297861-B | Compounds and uses thereof | 福宏治疗公司 | 2024-07-12 | — | — | CN | disclosed |
| US-20230145003-A1 | COMPOUNDS AND USES THEREOF | FOGHORN THERAPEUTICS INC. | 2023-05-11 | — | — | US | disclosed |
| CN-115297861-A | Compound and use thereof | 福宏治疗公司 | 2022-11-04 | — | — | CN | disclosed |
| US-20220000877-A1 | AQUEOUS COMPOSITION, IN PARTICULAR FOR TREATING MUCOSA AND/OR WOUNDS | B. BRAUN MELSUNGEN AG (DE) | 2022-01-06 | — | — | US | disclosed |
| US-20210401848-A1 | AQUEOUS COMPOSITION, IN PARTICULAR FOR TREATING MUCOSA AND/OR WOUNDS | B. BRAUN MELSUNGEN AG (DE) | 2021-12-30 | — | — | US | disclosed |
| EP-3886805-A1 | AQUEOUS COMPOSITION, IN PARTICULAR FOR TREATING MUCOSA AND/OR WOUNDS | B. Braun Melsungen AG (DE) | 2021-10-06 | — | — | EP | disclosed |
| EP-0882724-B1 | CYCLIC PHENOL SULFIDE CONTAINING SULFINYL OR SULFONYL GROUP AND PROCESS FOR PREPARING THE SAME | COSMO RES INST (JP) | 2001-11-07 | — | — | EP | disclosed |
| EP-0731102-B1 | Cyclic phenol sulfide and process for producing the same | COSMO RES INST (JP) | 2001-11-07 | — | — | EP | disclosed |
| US-5998631-A | Cyclic phenol sulfide having at least one sulfinyl or sulfonyl group and process for producing the same | COSMO RESEARCH INSTITUTE (JP) | 1999-12-07 | — | — | US | disclosed |
| EP-0882724-A1 | CYCLIC PHENOL SULFIDE CONTAINING SULFINYL OR SULFONYL GROUP AND PROCESS FOR PREPARING THE SAME | COSMO RESEARCH INSTITUTE (JP) | 1998-12-09 | — | — | EP | disclosed |
| US-5824808-A | Cyclic phenol sulfide and process for producing the same | COSMO RESEARCH INSTITUTE (JP) | 1998-10-20 | — | — | US | disclosed |
| EP-0731102-A1 | Cyclic phenol sulfide and process for producing the same | COSMO RESEARCH INSTITUTE (JP) | 1996-09-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220000877-A1 | AQUEOUS COMPOSITION, IN PARTICULAR FOR TREATING MUCOSA AND/OR WOUNDS | MUC1, DSG1, AQP3 | ALDH1A1 3087/4885HPGD 2138/4885ALOX15 3168/4885 |
| US-20230145003-A1 | COMPOUNDS AND USES THEREOF | VHL, CLN6, TFEB | ALDH1A1 2571/4885HPGD 3705/4885ALOX15 3537/4885 |
| US-20210401848-A1 | AQUEOUS COMPOSITION, IN PARTICULAR FOR TREATING MUCOSA AND/OR WOUNDS | DSP, DSG1, MUC1 | ALDH1A1 2335/4885HPGD 2395/4885ALOX15 2654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.